{
    "name": "Reports",
    "number": "116",
    "text": "[\u00a7325-116]\u00a0 Reports.\u00a0 The department, on or before January\u00a01 of each year, shall submit a report to the oversight committee.\u00a0 The report shall include:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Information as to the number of participants served and the number of needles and syringes distributed;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 A demographic profile of the participants served, including but not limited to: \u00a0age, sex, ethnicity, area of residence, occupation, types of drugs used, length of drug use, and frequency of injection;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Impact of the program on needle and syringe sharing and other high risk behavior;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Data on participants regarding HIV testing, counseling, drug treatment, and other social services, including referrals for HIV testing and counseling and for drug abuse treatment;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Impact on the transmission of HIV infection among injection drug users;\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 Impact on behaviors that caused participants to be at risk for HIV transmission such as frequency of drug use and needle sharing;\n\u00a0\u00a0\u00a0\u00a0 (7)\u00a0 An assessment of the cost-effectiveness of the program versus direct and indirect costs of HIV infection; and\n\u00a0\u00a0\u00a0\u00a0 (8)\u00a0 Information on the percentage of persons served through treatment programs for injection drug users funded through the department that were attributed to needle exchange referrals.\n\u00a0\u00a0\u00a0\u00a0 The report shall address the strengths and weaknesses of the program, the advisability of its continuation, amendments to the law, if appropriate, and other matters that may be helpful to the oversight committee in evaluating the program's efficacy. [L 1992, c 152, pt of \u00a72]"
}